Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0939920150470040949
´ëÇѾÏÇÐȸÁö
2015 Volume.47 No. 4 p.949 ~ p.953
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
Woo Hyun-Sun

Lee Kyoung-Hwa
Yoon Phill-Hoon
Kim Su-Ji
Park In-Keun
Kim Young-Saing
Ahn Hee-Kyung
Hong Jun-Shik
Shin Dong-Bok
Sym Sun-Jin
Abstract
Oxaliplatin is a third-generation platinum derivative used for metastatic or advanced colorectal cancer treatment. Although myelosuppression is the most common cause of oxaliplatin-induced thrombocytopenia, rare cases of oxaliplatin-induced immune-mediated thrombocytopenia are reported. We report a case of a 57-year-old woman with colon cancer who developed gum bleeding and petechiae after oxaliplatin infusion. Laboratory tests revealed grade 4 thrombocytopenia and grade 4 neutropenia. She recovered from the thrombocytopenia and accompanying neutropenia within 4 days with no recurrence following discontinuation of oxaliplatin. Physicians need to be aware of the risk of severe acute thrombocytopenia following oxaliplatin administration.
KEYWORD
Oxaliplatin, Colorectal neoplasms, Thrombocytopenia, Neutropenia
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø